NCT04964960 2025-10-31Pembro+Chemo in Brain MetsUniversity of KentuckyPhase 2 Terminated3 enrolled 7 charts
NCT04717375 2025-08-07Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid TumorsSanofiPhase 1/2 Terminated125 enrolled
NCT05241873 2025-02-10(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion MutationsBlueprint Medicines CorporationPhase 1 Terminated103 enrolled
NCT05153408 2023-06-18(HARMONY) Study of BLU-701 in EGFR-mutant NSCLCBlueprint Medicines CorporationPhase 1 Terminated20 enrolled
NCT00394147 2022-08-05Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck CancerFox Chase Cancer CenterPhase 2 Terminated17 enrolled 8 charts
NCT02117024 2020-02-05A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung CancerHeat BiologicsPhase 2 Terminated66 enrolled 17 charts
NCT02322281 2019-08-14TIGER-3: Open Label, Multicenter Study of Rociletinib (CO-1686) Mono Therapy Versus Single-agent Cytotoxic Chemotherapy in Patients With Mutant EGFR NSCLC Who Have Failed at Least One Previous EGFR-Directed TKI and Platinum-doublet ChemotherapyClovis Oncology, Inc.Phase 3 Terminated149 enrolled 17 charts
NCT00733031 2010-12-10Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918AstraZenecaPhase 1 Terminated75 enrolled